It gives me a great sense of pride and delight to write this. We all change as we traverse the pathway of our lives. I have ...

The Notification Letter has no immediate effect on the Company's listing on the Nasdaq Capital Market at this time, nor are the Company's business operations affected ...

Telix Pharmaceuticals Limited today announces preliminary results from the Phase 2 IPAX-Linz study of TLX101 (131I-iodofalan[1]) in recurrent high-grade glioma (brain cancer), substantiating the ...

Vivos Inc. (OTCQB: RDGL) is pleased to share new developments in its ongoing human clinical trial in India for RadioGel® Precision Radionuclide Therapy ...

Learn how environmental pollutants contribute to chronic illness and discover how the principles of environmental medicine ...